BIOLOGICAL SAMPLING DEVICE AND METHOD OF USE
Provided herein are methods and a device for collecting biological samples. In particular, the present disclosure relates to a device designed to specifically capture samples within the target areas of a patient for specific cell collection for particular diagnosis.
1 . A method for collecting a biological sample in a patient, the method comprising:
positioning, at a collection site in a gastrointestinal tract associated with Graft Versus Host Disease (GVHD), a device provided with a collection portion having a first axial end portion and a second axial end portion;
axially moving the second axial end portion, relative to the first axial end portion, from a collapsed position within the first axial end portion into an expanded position; and
collecting the biological sample with the second axial end portion in the expanded position.
2 . The method of claim 1 , further comprising axially moving the second axial end portion into the first axial end portion from the expanded position into the collapsed position to protect the biological sample.
3 . (canceled)
4 . The method of claim 1 , wherein the step of axially moving the second axial end portion from the collapsed position into the expanded position includes moving the second axial end portion from a concave shape to a convex shape, or wherein the step of axially moving the second axial end portion from the expanded position into the collapsed position includes moving the second axial end portion from a convex shape to a concave shape.
5 . (canceled)
6 . (canceled)
7 . The method of claim 1 , wherein the step of positioning the collection portion of the device into the gastrointestinal tract includes swallowing the collection portion.
8 . (canceled)
9 . (canceled)
10 . (canceled)
11 . The method of claim 1 , further comprising performing at least one of pathological analysis, diagnostic analysis, and cell analysis on the biological sample including esophageal cells.
12 . The method of claim 1 , further comprising removing the device from the gastrointestinal tract of the patient.
13 . The method of claim 1 , further comprising detecting at least one morphological, histological, or biological marker of GVHD from the biological sample including esophageal cells, wherein the presence of at least one morphological, histological, or biological marker of GVHD indicates that the patient has or is suspected of having GVHD.
14 . (canceled)
15 . A method for collecting a biological sample in a patient, the method comprising:
positioning, at a collection site in an esophagus associated with Cytomegalovirus Esophagitis (CMV), a device provided with a collection portion having a first axial end portion and a second axial end portion;
axially moving the second axial end portion, relative to the first axial end portion, from a collapsed position within the first axial end portion into an expanded position; and
collecting the biological sample with the second axial end portion in the expanded position.
16 . The method of claim 15 , further comprising axially moving the second axial end portion into the first axial end portion from the expanded position into the collapsed position to protect the biological sample.
17 . (canceled)
18 . The method of claim 15 , wherein the step of axially moving the second axial end portion from the collapsed position into the expanded position includes moving the second axial end portion from a concave shape to a convex shape, or wherein the step of axially moving the second axial end portion from the expanded position into the collapsed position includes moving the second axial end portion from a convex shape to a concave shape.
19 . (canceled)
20 . (canceled)
21 . The method of claim 15 , wherein the step of positioning the collection portion of the device into the esophagus includes swallowing the collection portion.
22 . (canceled)
23 . (canceled)
24 . (canceled)
25 . The method of claim 15 , further comprising performing at least one of pathological analysis, diagnostic analysis, and cell analysis on the biological sample including esophageal cells.
26 . The method of claim 15 , further comprising removing the device from the esophagus of the patient.
27 . The method of claim 15 , further comprising detecting at least one morphological, histological, or biological marker of CMV from the biological sample including esophageal cells, wherein the presence of at least one morphological, histological, or biological marker of CMV indicates that the patient has or is suspected of having CMV.
28 . (canceled)
29 . A method for collecting a biological sample in a patient, the method comprising:
positioning, at a collection site in at least one of mouth, throat, and vagina associated with Candidiasis, a device provided with a collection portion having a first axial end portion and a second axial end portion;
axially moving the second axial end portion, relative to the first axial end portion, from a collapsed position within the first axial end portion into an expanded position; and
collecting the biological sample with the second axial end portion in the expanded position.
30 . The method of claim 29 , further comprising axially moving the second axial end portion into the first axial end portion from the expanded position into the collapsed position to protect the biological sample.
31 . The method of claim 29 , wherein the biological sample includes buccal cells, squamous cells, vaginal cells, and/or Candida cells.
32 . The method of claim 29 , wherein the step of axially moving the second axial end portion from the collapsed position into the expanded position includes moving the second axial end portion from a concave shape to a convex shape, or wherein the step of axially moving the second axial end portion from the expanded position into the collapsed position includes moving the second axial end portion from a convex shape to a concave shape.
33 . (canceled)
34 . (canceled)
35 . The method of claim 29 , wherein the step of positioning the collection portion of the device into the at least one of mouth, throat, and vagina includes swallowing the collection portion.
36 . (canceled)
37 . (canceled)
38 . (canceled)
39 . The method of claim 29 , further comprising performing at least one of pathological analysis, diagnostic analysis, and cell analysis on the biological sample including Candida cells.
40 . The method of claim 29 , further comprising removing the device from the at least one of mouth, throat, and vagina of the patient.
41 . The method of claim 29 , further comprising detecting at least one morphological, histological, or biological marker of Candidiasis from the biological sample including buccal cells, squamous cells, vaginal cells, and/or Candida cells, wherein the presence of at least one morphological, histological, or biological marker of Candidiasis from the biological sample including buccal cells, squamous cells, vaginal cells, and/or Candida cells indicates that the patient has or is suspected of having Candidiasis.
42 . (canceled)